CDC 57.126 MDRO or CDI Infection Event

[NCEZID] The National Healthcare Safety Network (NHSN)

57.126_MDROInfectionEvent_BLANK.DOCX

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date: 01/31/2021

www.cdc.gov/nhsn

MDRO or CDI Infection Event

Page 1 of 4




*Required for saving

Facility ID:




**Required for completion

Event #:

*Patient ID:

Social Security #:

Secondary ID:

Medicare #:

Patient Name, Last: First: Middle:

*Gender: M F Other

*Date of Birth:

Ethnicity (Specify):

Race (Specify):

Event Details

*Event Type:

[For Event Type = BSI, PNEU, SSI, or UTI use the event specific from]

*Date of Event:


Post Procedure Event: Yes No

Date of Procedure:

MDRO/CDI Infection Surveillance: Yes

NHSN Procedure Code:

ICD-10-PCS or CPT Procedure Code:

*Specific Organism Type: (Select up to 3)

MRSA

MSSA

VRE

CephR-Klebsiella

CRE-E. coli

CRE-Enterobacter

CRE-Klebsiella

MDR-Acinetobacter

C. difficile

*Date Admitted to Facility:

*Location:

*Specific Event Type (used only for CDC defined events):

Specify Criteria Used (check all that apply)

Signs and Symptoms

Laboratory or Diagnostic Testing

Abscess

Heat

Dysuria

Organism(s) identified

Apnea

Hypotension

Fever

Not cultured

Bradycardia

Hypothermia

Bilious aspirate

Organism(s) identified from blood specimen+

Cough

Lethargy

Erythema or redness

Other positive laboratory tests+

Vomiting

Nausea

Suprapubic tenderness

> 15 colonies cultured from IV cannula tip using semiquantitative culture method

Abdominal distension

Pain or tenderness

Pneumatosis intestinalis by radiograph

Drainage or material+

Portal venous gas (Hepatobiliary gas) by radiograph

Wheezing, rales or rhonchi

Pneumoperitoneum by radiograph

Diarrhea+

Imaging test evidence of infection+

Swelling or inflammation


Occult or gross blood in stools (with no rectal fissure)


Surgical evidence of extensive bowel necrosis (>2 cm of bowel affected)

Clinical Diagnosis

Surgical evidence of pneumatosis intestinalis with or without intestinal perforation

Physician diagnosis of this event type+

Physician institutes appropriate antimicrobial therapy+

Other evidence of infection found on invasive procedure, gross anatomic exam, or histopathologic exam +


Other signs and symptoms+


+ Per specific site criteria

Clostridioides difficile Infection


*Admitted to ICU for CDI complications: Yes No

*Surgery for CDI complications: Yes No

* Secondary Bloodstream Infection: Yes No


**Died: Yes No

Event contributed to death? Yes No

Discharge Date: ____/____/______

*Pathogens Identified: Yes No If yes, specify on Page 2


Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.126 (Front) Rev 6 V. 8.6

MDRO or CDI Infection Event

Page 2 of 4

Pathogen #

Gram-positive Organisms


_______


Staphylococcus coagulase-negative


VANC

S I R N

(specify species if available):

____________


_______


____Enterococcus faecium


____Enterococcus faecalis

____Enterococcus spp.

(Only those not identified to the species level)


DAPTO

S NS N


GENTHL§

S R N


LNZ

S I R N


VANC

S I R N




_______


Staphylococcus aureus


CIPRO/LEVO/MOXI

S I R N


CLIND

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


ERYTH

S I R N


GENT

S I R N


LNZ

S R N


OX/CEFOX/METH

S I R N


RIF

S I R N


TETRA

S I R N


TIG

S NS N


TMZ

S I R N


VANC

S I R N


Pathogen #

Gram-negative Organisms


_______


Acinetobacter

(specify species)

____________


AMK

S I R N


AMPSUL

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N


GENT

S I R N


IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Escherichia coli


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I/S-DD R N


CEFOT/CEFTRX

S I R N


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S R N


ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N


TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Enterobacter

(specify species)

____________


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I/S-DD R N


CEFOT/CEFTRX

S I R N


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S R N


ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N


TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______

____Klebsiella

pneumonia


____Klebsiella

oxytoca



AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I/S-DD R N


CEFOT/CEFTRX

S I R N


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S R N


ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N


TIG

S I R N


TMZ

S I R N


TOBRA

S I R N


MDRO or CDI Infection Event

Page 3 of 4

Pathogen #

Gram-negative Organisms (continued)


_______


Pseudomonas aeruginosa


AMK

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N


GENT

S I R N


IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TOBRA

S I R N

Pathogen #

Fungal Organisms

_______

Candida

(specify species if available)

____________


ANID

S I R N

CASPO

S NS N

FLUCO

S S-DD R N

FLUCY

S I R N

ITRA

S S-DD R N

MICA

S NS N

VORI

S S-DD R N

Pathogen #

Other Organisms

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N



Result Codes

S = Susceptible I = Intermediate R = Resistant NS = Non-susceptible S-DD = Susceptible-dose dependent N = Not tested

§ GENTHL results: S = Susceptible/Synergistic and R = Resistant/Not Synergistic

Clinical breakpoints have not been set by FDA or CLSI, Sensitive and Resistant designations should be based upon epidemiological cutoffs of Sensitive MIC ≤ 2 and Resistant MIC ≥ 4



Drug Codes:




AMK = amikacin

CEFTRX = ceftriaxone

FLUCY = flucytosine

OX = oxacillin

AMP = ampicillin

CEFUR= cefuroxime

GENT = gentamicin

PB = polymyxin B

AMPSUL = ampicillin/sulbactam

CETET= cefotetan

GENTHL = gentamicin –high level test

PIP = piperacillin

AMXCLV = amoxicillin/clavulanic acid

CIPRO = ciprofloxacin

IMI = imipenem

PIPTAZ = piperacillin/tazobactam

ANID = anidulafungin

CLIND = clindamycin

ITRA = itraconazole

RIF = rifampin

AZT = aztreonam

COL = colistin

LEVO = levofloxacin

TETRA = tetracycline

CASPO = caspofungin

DAPTO = daptomycin

LNZ = linezolid

TIG = tigecycline

CEFAZ= cefazolin

DORI = doripenem

MERO = meropenem

TMZ = trimethoprim/sulfamethoxazole

CEFEP = cefepime

DOXY = doxycycline

METH = methicillin

TOBRA = tobramycin

CEFOT = cefotaxime

ERTA = ertapenem

MICA = micafungin

VANC = vancomycin

CEFOX= cefoxitin

ERYTH = erythromycin

MINO = minocycline

VORI = voriconazole

CEFTAZ = ceftazidime

FLUCO = fluconazole

MOXI = moxifloxacin



MDRO or CDI Infection Event


Page 4 of 4

Custom Fields

Label

Label

_______________________

____/____/____

_______________________

____/____/_____

_______________________

_____________

_______________________

______________

_______________________

_____________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________

_______________________

______________


Comments

















































File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Title57.129_MDRO Infection Event
SubjectNHSN OMB FORM 2018
AuthorCDC/NCZEID/DHQP
File Modified0000-00-00
File Created2024-09-16

© 2024 OMB.report | Privacy Policy